| An accelerated shift in the use of remote systems in epilepsy due to the COVID-19 pandemic M Kuchenbuch, G d'Onofrio, E Wirrell, Y Jiang, S Dupont, ZM Grinspan, ... Epilepsy & Behavior 112, 107376, 2020 | 42 | 2020 |
| Slow titration of cannabidiol add-on in drug-resistant epilepsies can improve safety with maintained efficacy in an open-label study G D'Onofrio, M Kuchenbuch, C Hachon-Le Camus, B Desnous, V Staath, ... Frontiers in Neurology 11, 829, 2020 | 26 | 2020 |
| Add‐on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy M Kuchenbuch, G D'Onofrio, N Chemaly, G Barcia, T Teng, R Nabbout Epilepsia Open 5 (3), 496-500, 2020 | 18 | 2020 |
| Impact and management of drooling in children with neurological disorders: an Italian Delphi consensus A Riva, E Amadori, MS Vari, A Spalice, V Belcastro, M Viri, D Capodiferro, ... Italian Journal of Pediatrics 48 (1), 118, 2022 | 15 | 2022 |
| A European pilot study in Dravet Syndrome to delineate what really matters for the patients and families N Chemaly, M Kuchenbuch, T Teng, E Marie, G D'Onofrio, T Lo Barco, ... Epilepsia Open 9 (1), 388-396, 2024 | 10 | 2024 |
| Current and promising therapeutic options for Dravet syndrome A Riva, G D’Onofrio, E Amadori, D Tripodi, G Balagura, V Iurilli, MS Vari, ... Expert Opinion on Pharmacotherapy 23 (15), 1727-1736, 2022 | 10 | 2022 |
| Urinary metabotypes of newborns with perinatal asphyxia undergoing therapeutic hypothermia E Valerio, V Mardegan, M Stocchero, ME Cavicchiolo, P Pirillo, ... Plos one 17 (8), e0273175, 2022 | 8 | 2022 |
| A real‐life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy A Riva, R Roberti, G D'Onofrio, MS Vari, E Amadori, V De Giorgis, ... Epilepsia Open 8 (3), 1142-1150, 2023 | 6 | 2023 |
| Clinical and Neurophysiologic Phenotypes in Neonates With BRAT1 Encephalopathy E Carapancea, MC Cornet, M Milh, L De Cosmo, EJ Huang, T Granata, ... Neurology 100 (12), e1234-e1247, 2023 | 6 | 2023 |
| Novel biallelic variants expand the phenotype of NAA20‐related syndrome G D'Onofrio, C Cuccurullo, SK Larsen, M Severino, A D'Amico, K Brønstad, ... Clinical Genetics 104 (3), 371-376, 2023 | 5 | 2023 |
| Genotype–phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder G D’Onofrio, A Accogli, M Severino, H Caliskan, T Kokotović, A Blazekovic, ... Human Genetics 142 (7), 909-925, 2023 | 5 | 2023 |
| Influenza-associated hemolytic uremic syndrome: The pathogenic role of the virus V Silecchia, G D’Onofrio, E Valerio, G Rubin, E Vidal, L Murer Clinical nephrology. Case Studies 9, 45, 2021 | 5 | 2021 |
| Treatment of refractory epilepsy with MEK inhibitor in patients with RASopathy G D'Onofrio, MA Delrue, A Lortie, C Marquis, P Striano, M Jaworski, ... Pediatric Neurology 148, 148-151, 2023 | 4 | 2023 |
| Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care–an overview G D’Onofrio, A Riva, E Amadori, S Lattanzi, K Rose, A Verrotti, P Striano Expert Opinion on Drug Metabolism & Toxicology 18 (9), 575-585, 2022 | 4 | 2022 |
| Cannabidiol add-on in glycosylphosphatidylinositol-related drug-resistant epilepsy A Riva, G D'Onofrio, A Pisati, R Roberti, E Amadori, F Bosch, ... Cannabis and Cannabinoid Research 9 (4), 990-995, 2024 | 3 | 2024 |
| Myoclonus: Differential diagnosis and current management A Riva, G D'Onofrio, E Ferlazzo, A Pascarella, E Pasini, S Franceschetti, ... Epilepsia Open 9 (2), 486-500, 2024 | 3 | 2024 |
| A PAK1 mutational hotspot within the regulatory CRIPaK domain is associated with severe neurodevelopmental disorders in children G Scorrano, G D'Onofrio, A Accogli, M Severino, R Buchert, U Kotzaeridou, ... Pediatric Neurology 149, 84-92, 2023 | 3 | 2023 |
| Paroxysmal limb dystonias associated with GABBR2 pathogenic variant: A case-based literature review G D'Onofrio, A Riva, G Di Rosa, S Efthymiou, E Gitto, F Madia, A Accogli, ... Brain and Development 44 (7), 469-473, 2022 | 3 | 2022 |
| Sleep exacerbations and facial twitching: diagnostic clues for ADCY5-related dyskinesias M Nosadini, G D'Onofrio, MF Pelizza, C Luisi, D Padrin, L Baggio, ... Neuropediatrics 52 (03), 208-211, 2021 | 3 | 2021 |
| Genotype–phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders P Borgia, S Baldassari, N Pedemonte, E Alkhunaizi, G D’Onofrio, ... Orphanet Journal of Rare Diseases 17 (1), 286, 2022 | 2 | 2022 |
